Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EPS (Basic) (2024 - 2026)

Beta Bionics recorded quarterly EPS (Basic) of -$0.49 in Q1 2026, down 68.97% quarter-over-quarter from -$0.29 in Q4 2025, and up 47.31% year-over-year from -$0.33 in Q1 2025.

Beta Bionics' EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.49 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 47.31% year-over-year to -$0.49; the TTM figure through Mar 2026 stood at -$1.5 (up 80.0% YoY), while the FY2025 annual figure was -$1.81, up 78.95% from the prior year.
  • EPS (Basic) came in at -$0.49 for Q1 2026 at Beta Bionics, down from -$0.29 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.29 in Q4 2025 to a low of -$2.74 in Q4 2024.
  • A 3-year average of -$1.23 and a median of -$0.93 in 2025 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) surged 89.42% in 2025 and surged 47.31% in 2026, its largest moves.
  • Beta Bionics' EPS (Basic) stood at -$2.74 in 2024, then soared by 89.42% to -$0.29 in 2025, then plunged by 68.97% to -$0.49 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods registered -$0.49, -$0.29, and -$0.33 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.62
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.95
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.52
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.25
10 Beta Bionics 572.34 Mn 542.03 Mn 16.44 Mn -0.49

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.49
Dec 31, 2025 -0.29
Sep 30, 2025 -0.33
Jun 30, 2025 -0.39
Mar 31, 2025 -0.93
Dec 31, 2024 -2.74
Sep 30, 2024 -1.46
Jun 30, 2024 -2.37
Mar 31, 2024 -2.07